GlassScriptPhysician profile
Ajith P Nair
NPI 1679747950
$79,556.37
in general payments reported to CMS, 2019-2025
42 companies · $5,127 in 2025
The $5,127 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,652 · 2020: $3,087 · 2021: $9,811 · 2022: $17K · 2023: $27K · 2024: $14K · 2025: $5,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Honoraria: $9,400 · Food and Beverage: $7,652 · Travel and Lodging: $3,094 · Consulting Fee: $1,706 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,725.00 |
| Honoraria | $9,400.00 |
| Food and Beverage | $7,652.40 |
| Travel and Lodging | $3,093.57 |
| Consulting Fee | $1,706.25 |
| Education | $151.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $28,160.36 | 2019-2025 | Opsumit, Uptravi |
| Impulse Dynamics (USA) INC. | $21,469.39 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $20,611.83 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Heartmate Touch |
| Abiomed | $2,808.66 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,037.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $771.05 | 2019-2025 | |
| United Therapeutics Corporation | $606.77 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Cvrx, INC. | $490.24 | 2019-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $479.19 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Amgen INC. | $328.60 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $303.92 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $214.53 | 2020-2025 | Wainua |
| Atricure, INC. | $210.33 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $207.75 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $184.03 | 2019-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $182.80 | 2021-2023 | Accucinch |
| Akcea Therapeutics, INC. | $166.12 | 2020-2021 | |
| Bridgebio Pharma, INC. | $157.39 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $125.16 | 2023-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $124.31 | 2019 | |
| Scpharmaceuticals INC. | $108.69 | 2023-2025 | |
| Genzyme Corporation | $96.67 | 2021 | |
| Daiichi Sankyo INC. | $96.32 | 2023-2024 | Injectafer |
| Gilead Sciences, INC. | $77.60 | 2019 | |
| Medtronic, INC. | $69.97 | 2021-2023 | Cobalt Dr Mri Surescan |
| Sandoz INC. | $64.24 | 2019-2023 | Treprostinil |
| Alnylam Pharmaceuticals INC. | $45.16 | 2022-2023 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $43.87 | 2024 | |
| Janssen Pharmaceuticals, INC | $39.09 | 2019 | |
| Kestra Medical Technology Services, INC. | $38.81 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.04 | 2024 | Jardiance |
| Analog Devices INC. | $32.67 | 2025 | Sensinel Cpm Wearable |
| Cardiovascular Systems INC. | $28.55 | 2020 | |
| Acceleron Pharma, INC. | $24.54 | 2021 | |
| Baxter Healthcare | $22.14 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Portola Pharmaceuticals, LLC | $21.41 | 2020 | |
| Irhythm Technologies, INC. | $19.19 | 2022 | |
| Heartflow, INC. | $17.13 | 2024 | |
| Chiesi USA, INC. | $16.62 | 2019 | |
| Mannkind Corporation | $16.05 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajith Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.